Grant: Operating Grant
University of Calgary
$375,254.00
Molecular Auditing: An Evaluation of Tissue Specimen Misidentification
FY 2010-11
Summary
Laboratory errors, including specimen misidentification, can have catastrophic impact to patients. It is not uncommon for such errors to be recognized by the laboratory or submitting physicians, and the errors can then be corrected. Some specimens may be at higher risk for misidentification errors, such as gastrointestinal biopsies or prostate and breast needle biopsies, which are accrued and submitted in high numbers by busy clinicians,. We seek to test the hypothesis that there is a background rate of unsuspected specimen mismatch/misidentification in tissue biopsies submitted for microscopic examination to a pathology laboratory. If our hypothesis is correct, we will have identified a significant source of potential adverse affects for patients which may justify changes to the current processes used to submit and evaluate small tissue biopsies.
Department
Program
Operating Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
210799
Name
Demetrick Douglas J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
Molecular Auditing: An Evaluation of Tissue Specimen Misidentification
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$375,254
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biopsy; Dna Fingerprint; Laboratory Error; Misidentification; Mismatch; Molecular Auditing; Patient Safety; Tissue Specimen
Abstract
Laboratory errors, including specimen misidentification, can have catastrophic impact to patients. It is not uncommon for such errors to be recognized by the laboratory or submitting physicians, and the errors can then be corrected. Some specimens may be at higher risk for misidentification errors, such as gastrointestinal biopsies or prostate and breast needle biopsies, which are accrued and submitted in high numbers by busy clinicians,. We seek to test the hypothesis that there is a background rate of unsuspected specimen mismatch/misidentification in tissue biopsies submitted for microscopic examination to a pathology laboratory. If our hypothesis is correct, we will have identified a significant source of potential adverse affects for patients which may justify changes to the current processes used to submit and evaluate small tissue biopsies.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Demetrick, Douglas J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $375,254~ $0~